Home The Word Brain	My Amedeo FAQ Privacy About
	Amedeo Chinese For Medical Students & Physicians A complete 20-lesson, 300-page Chinese course with a companion app in 21 languages — free forever. Download the free PDF: Amedeo Chinese PDF

Drug Resistance

Free Subscription 15.06.2026 1 Am J Trop Med Hyg 12 Antimicrob Agents Chemother 2 Clin Infect Dis 3 Emerg Infect Dis 1 Infect Control Hosp Epidemiol 4 Int J Antimicrob Agents 2 J Antimicrob Chemother 1 J Clin Microbiol 1 Nature 1 PLoS Genet 7 PLoS One 1 Proc Natl Acad Sci U S A

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Trop Med Hyg

1. KINDU M, Moges F, Negash G, Tigabu Z, et al
   Multidrug-Resistant and Carbapenemase-Producing Gram-Negative Bacteria among Intensive Care Unit Patients in Amhara National Regional State, Ethiopia.
   Am J Trop Med Hyg. 2026;114:1046-1052.
   PubMed         Abstract available
   
   

   
   Antimicrob Agents Chemother

2. MIYASHITA N, Ogata M, Fukuda N, Yamura A, et al
   Efficacy of garenoxacin in patients with macrolide-resistant Mycoplasma pneumoniae pneumonia.
   Antimicrob Agents Chemother. 2026 Jun 11:e0002526. doi: 10.1128/aac.00025.
   PubMed         Abstract available
   
   
3. COLLAR GDS, Dornelles LS, Salvador JC, Pinto JB, et al
   Consistent in vitro activity of sulbactam-durlobactam against genetically diverse carbapenem-resistant Acinetobacter baumannii in a high-endemic Brazilian setting.
   Antimicrob Agents Chemother. 2026 Jun 12:e0010926. doi: 10.1128/aac.00109.
   PubMed         Abstract available
   
   
4. WU M, Chen Y, Su M, Wu H, et al
   Domestic travel as a driver for the dissemination of mcr-1 in healthy travelers in China: a prospective, genomic epidemiological and gut microbiome study.
   Antimicrob Agents Chemother. 2026;70:e0174625.
   PubMed         Abstract available
   
   
5. YI Q-L, Xu K-W, Guo P-H, Li L, et al
   Surveillance for invasive candidiasis in China (CHIF-NET 2018-2021): rising antifungal resistance observed in a nationwide longitudinal study.
   Antimicrob Agents Chemother. 2026;70:e0003526.
   PubMed         Abstract available
   
   
6. MORGAN GM, Kimbrough JH, Karr MH, Thompson J, et al
   Determination of frequency of spontaneous resistance for gepotidacin and levofloxacin against a collection of gram-positive and gram-negative organisms.
   Antimicrob Agents Chemother. 2026;70:e0183225.
   PubMed         Abstract available
   
   
7. LIU Y, Hong H, Huang Q, Fan L, et al
   Characterization of KPC-160, a novel Omega-loop-deleted KPC variant on a dual-copy plasmid that confers cefiderocol resistance.
   Antimicrob Agents Chemother. 2026;70:e0135825.
   PubMed         Abstract available
   
   
8. WALKER MM, Roberts JA, Li Y, Naicker S, et al
   Evaluating the efficacy of ceftazidime/avibactam plus amikacin combination therapy as a carbapenem-sparing agent against ceftazidime/avibactam-resistant Escherichia coli using a hollow fiber infection model: a proof-of-concept study.
   Antimicrob Agents Chemother. 2026;70:e0137725.
   PubMed         Abstract available
   
   
9. WANG Y, Wang Y, Zhai W, Chen W, et al
   Emergence of tet(X4)-positive Klebsiella isolates from aquatic products in Hainan, China.
   Antimicrob Agents Chemother. 2026;70:e0161825.
   PubMed         Abstract available
   
   
10. VAHEDI-SHAHANDASHTI R, Nickel A-S, Eisele D, Lass-Florl C, et al
    Can voriconazole gradient diffusion testing results be extrapolated to isavuconazole and posaconazole in Aspergillus spp.? Comparative analysis with CLSI broth microdilution and cyp51A gene sequencing.
    Antimicrob Agents Chemother. 2026 May 15:e0181325. doi: 10.1128/aac.01813.
    PubMed         Abstract available
    
    
11. KUNZ COYNE AJ, Judd C, Lucas K, Al Musawa M, et al
    Ceftazidime-avibactam for multidrug-resistant gram-negative infections: outcomes and timing of initiation across 22 U.S. medical centers.
    Antimicrob Agents Chemother. 2026;70:e0026826.
    PubMed         Abstract available
    
    
12. SUN W, Tian M, Wang X, Jiang S, et al
    The protective effect of Schisandrin C against methicillin-resistant Staphylococcus aureus-induced otitis media.
    Antimicrob Agents Chemother. 2026 Jun 10:e0009526. doi: 10.1128/aac.00095.
    PubMed         Abstract available
    
    
13. NOLAN AC, Kelly JB, Ahn J, Shinde D, et al
    The beta-lactam adjuvant guanosine potentiates anti-folate antibiotics and pyrimidine synthesis inhibitors by depleting thymidine in methicillin-resistant Staphylococcus aureus.
    Antimicrob Agents Chemother. 2026 Jun 10:e0037726. doi: 10.1128/aac.00377.
    PubMed         Abstract available
    
    

    
    Clin Infect Dis

14. BAVARO DF, Belati A, Sacchet D, Cilli A, et al
    Anti-Methicillin-Resistant Staphylococcus aureus (MRSA) Cephalosporins Plus Daptomycin as Initial Therapy for MRSA Bacteremia: Does a "Hit Hard and Fast" Strategy Improve Outcomes?
    Clin Infect Dis. 2026 Jun 9:ciag228. doi: 10.1093.
    PubMed         Abstract available
    
    
15. ALIGUI AF, Hor SW, Blanco-Arevalo A, Gupta A, et al
    Challenges to Accessing Newer Antibiotics for Multidrug-resistant Bacterial Infections in Asia: A Literature Review of Multi-Stakeholder Perspectives.
    Clin Infect Dis. 2026;82.
    PubMed         Abstract available
    
    

    
    Emerg Infect Dis

16. YURAYART C, Yingchanakiat K, Thongbai A, Limsivilai O, et al
    In Vitro Antifungal Drug Susceptibility of Feline Sporothrix schenckii Complex Isolates, Thailand, 2023-2025.
    Emerg Infect Dis. 2026;32:925-932.
    PubMed         Abstract available
    
    
17. BREEZE B, Babiker A, Konda S, Robinson AL, et al
    Role of Households with Children in Community Spread of Multidrug-Resistant Enterobacterales, St. Louis, Missouri, USA.
    Emerg Infect Dis. 2026;32:914-924.
    PubMed         Abstract available
    
    
18. KITTIYAOWAMARN R, Sangprasert P, Girdthep N, Pharanut S, et al
    Emergence of Ceftriaxone-Resistant Neisseria gonorrhoeae penA-60-Carrying Strains, Thailand, 2025.
    Emerg Infect Dis. 2026;32:985-989.
    PubMed         Abstract available
    
    

    
    Infect Control Hosp Epidemiol

19. BECK A, Driscoll J, Hoetzer K, Abraham AG, et al
    Association between social vulnerability index and rates of carbapenem-resistant enterobacterales infections in the Denver metropolitan region, 2016-2019.
    Infect Control Hosp Epidemiol. 2026 Jun 11:1-3. doi: 10.1017/ice.2026.10402.
    PubMed         Abstract available
    
    

    
    Int J Antimicrob Agents

20. GIULIANO S, Cojutti P, Bulfoni M, Cotrufo M, et al
    Emergence of Dalbavancin Non-Susceptible Methicillin-Resistant Staphylococcus epidermidis (MRSE) in a Patient Treated With Dalbavancin prolonged therapy: Case Report, Therapeutic Drug Monitoring and Genomic Characterization.
    Int J Antimicrob Agents. 2026 Jun 5:107877.
    PubMed         Abstract available
    
    
21. ZAMRI PJ, Wolky SA, Hernandez-Mitre MP, Liu X, et al
    Population pharmacokinetics of polymyxin B in critically ill patients with multi-drug-resistant (MDR) Acinetobacter baumannii and Pseudomonas aeruginosa infections.
    Int J Antimicrob Agents. 2026;67:107816.
    PubMed         Abstract available
    
    
22. HAO SY, Lin HY, Yeh PI, Hsiao HC, et al
    Multidrug-resistant Acinetobacter baumannii pneumonia in clinical therapy: A systematic review and network meta-analysis on effectiveness and safety of different antibiotic combination regimens.
    Int J Antimicrob Agents. 2026;67:107815.
    PubMed         Abstract available
    
    
23. BIANCO G, Findlay J, Comini S, Costa C, et al
    In vivo emergence of cross-resistance to ceftazidime/avibactam and cefiderocol through selection of KPC variants in Klebsiella pneumoniae clinical isolates.
    Int J Antimicrob Agents. 2026;67:107808.
    PubMed         Abstract available
    
    

    
    J Antimicrob Chemother

24. MUTURI C, Wu A, McShea K, Redding LE, et al
    Quantifying household-level sharing of antimicrobial-resistant pathogens between pets and their owners: a systematic review and meta-analysis.
    J Antimicrob Chemother. 2026;81:dkag195.
    PubMed         Abstract available
    
    
25. LI G, El-Deeb IM, Whyte HG, Blaskovich MAT, et al
    Newly identified antimicrobial activity of an 8-hydroxyquinoline-based ionophore against multidrug-resistant Enterococcus faecium and Staphylococcus aureus.
    J Antimicrob Chemother. 2026;81:dkag186.
    PubMed         Abstract available
    
    

    
    J Clin Microbiol

26. WEISS ZF, Basu SS
    Point-Counterpoint: The "obsoletogram"-are annual hospital antibiograms still relevant?
    J Clin Microbiol. 2026;64:e0047626.
    PubMed         Abstract available
    
    

    
    Nature

27. MADHUSOODANAN J
    AI is taking on antibiotic resistance - here's how.
    Nature. 2026;654:560-562.
    PubMed        
    
    

    
    PLoS Genet

28. ROULEAU FD, Dube AK, Pageau A, Desautels L, et al
    Predicting antifolate resistance in the unculturable fungal pathogen Pneumocystis jirovecii.
    PLoS Genet. 2026;22:e1012163.
    PubMed         Abstract available
    
    

    
    PLoS One

29. RAHMAN MM, Simu SS, Shahir NF, Israt S, et al
    Unveiling the bactericidal effects of extracts and phytocompounds from Eichhornia crassipes (Mart.) Solms against methicillin-resistant Staphylococcus aureus (MRSA): An in vitro and in silico approach.
    PLoS One. 2026;21:e0349750.
    PubMed         Abstract available
    
    
30. HOSSAIN MT, Fahim FJ, Rana S, Sultana N, et al
    Virulence determinants and toxin profile of methicillin resistant Staphylococcus aureus from commercial cheese in Bangladesh: A public health risk.
    PLoS One. 2026;21:e0350222.
    PubMed         Abstract available
    
    
31. WALTER B, Luck K, Adam M, Winter B, et al
    Prevalence of diphtheria and antimicrobial-resistant wound infections among asylum seekers in Heidelberg, Germany, August-October 2024.
    PLoS One. 2026;21:e0350513.
    PubMed         Abstract available
    
    
32. ZURIEGAT L, Itani R, Abu Hammour K, Abu-Farha R, et al
    Multidrug resistance and inappropriate empiric therapy as predictors of hospital stay in diabetic foot infections.
    PLoS One. 2026;21:e0350837.
    PubMed         Abstract available
    
    
33. STURARO MC, Silva RCCD, Simionatto S
    Ceftibuten-polymyxin B combination alters resistance and cell wall gene expression in multidrug-resistant Klebsiella pneumoniae.
    PLoS One. 2026;21:e0349583.
    PubMed         Abstract available
    
    
34. NARUSE H, Watanabe N, Koyama S, Tanaka S, et al
    Clinical performance of the BioFire Blood Culture Identification 2 panel for microorganism species identification and resistance gene detection in blood culture-positive specimens.
    PLoS One. 2026;21:e0350768.
    PubMed         Abstract available
    
    
35. ADHIKARI S, Khanal S, Adhikari A
    The livestock drinking water system as an active reservoir for antimicrobial resistance: A systematic review and one health gap analysis.
    PLoS One. 2026;21:e0349556.
    PubMed         Abstract available
    
    

    
    Proc Natl Acad Sci U S A

36. SHANNON A, Fattorini V, Sartre C, Chazot A, et al
    Consecutive catalytic steps of viral RNA polymerase and exonuclease suggest a way to overcome intrinsic nucleotide analogue resistance.
    Proc Natl Acad Sci U S A. 2026;123:e2605725123.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Drug Resistance is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum